Farmacogenética de la terapéutica anticoagulante

TE Klein, RB Altman, Niclas Eriksson, BF Gage, SE Kimmel, MT Lee, NA Limdi, D Page, DM Roden, MJ Wagner, MD Caldwell, JA Johnson, YT Chen, MS Wen, Y Caraco, I Achache, S Blotnick, M Muszkat, JG Shin, HS Kim, G Suarez-Kurtz, JA Perini, E Silva-Assuncao, JL Anderson, BD Horne, JF Carlquist, RL Berg, JK Burmester, BC Goh, SC Lee, F Kamali, E Sconce, AK Daly, AH Wu, TY Langaee, H Feng, L Cavallari, K Momary, M Pirmohamed, A Jorgensen, CH Toh, P Williamson, H McLeod, JP Evans, KE Weck, C Brensinger, Y Nakamura, T Mushiroda, D Veenstra, L Meckley, MJ Rieder, AE Rettie, M Wadelius, H Melhus, CM Stein, U Schwartz, D Kurnik, E Deych, P Lenzini, C Eby, LY Chen, P Deloukas, A Motsinger-Reif, H Sagreiya, BS Srinivasan, E Lantz, T Chang, M Ritchie, LS Lu, Estimation of the warfarin dose with clinical and pharmacogenetic data The New England Journal of Medicine. ,vol. 360, pp. 753- 764 ,(2009) , 10.1056/NEJMOA0809329

R. G. MACFARLANE, AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER Nature. ,vol. 202, pp. 498- 499 ,(1964) , 10.1038/202498A0

Francisco Pérez-Gómez, Ramón Bover, La nueva cascada de la coagulación y su posible influencia en el difícil equilibrio entre trombosis y hemorragia Revista Espanola De Cardiologia. ,vol. 60, pp. 1217- 1219 ,(2007) , 10.1157/13113924

Simone Rost, Andreas Fregin, Vytautas Ivaskevicius, Ernst Conzelmann, Konstanze Hörtnagel, Hans-Joachim Pelz, Knut Lappegard, Erhard Seifried, Inge Scharrer, Edward G. D. Tuddenham, Clemens R. Müller, Tim M. Strom, Johannes Oldenburg, Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 Nature. ,vol. 427, pp. 537- 541 ,(2004) , 10.1038/NATURE02214

Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott, Lei Shen, Richard D. Hockett, John T. Brandt, Joseph R. Walker, Elliott M. Antman, William Macias, Eugene Braunwald, Marc S. Sabatine, Cytochrome P-450 Polymorphisms and Response to Clopidogrel The New England Journal of Medicine. ,vol. 360, pp. 354- 362 ,(2009) , 10.1056/NEJMOA0809171

B. L. Chen, Y. Chen, J. H. Tu, Y. L. Li, W. Zhang, Q. Li, L. Fan, Z. R. Tan, D. L. Hu, D. Wang, L. S. Wang, D. S. OuYang, H. H. Zhou, Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms. The Journal of Clinical Pharmacology. ,vol. 49, pp. 574- 581 ,(2009) , 10.1177/0091270009333016

Liyan Miao, Jian Yang, Chenrong Huang, Zhenya Shen, Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients European Journal of Clinical Pharmacology. ,vol. 63, pp. 1135- 1141 ,(2007) , 10.1007/S00228-007-0381-6

R. De Caterina, S. Husted, L. Wallentin, G. Agnelli, F. Bachmann, C. Baigent, J. Jespersen, S. D. Kristensen, G. Montalescot, A. Siegbahn, F. W.A. Verheugt, J. Weitz, Anticoagulants in heart disease: current status and perspectives European Heart Journal. ,vol. 28, pp. 880- 913 ,(2007) , 10.1093/EURHEARTJ/EHL492

S E Kimmel, J Christie, C Kealey, Z Chen, M Price, C F Thorn, C M Brensinger, C W Newcomb, A S Whitehead, Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans. Pharmacogenomics Journal. ,vol. 8, pp. 53- 60 ,(2008) , 10.1038/SJ.TPJ.6500445

Johannes Oldenburg, Carville G. Bevans, Clemens R. Müller, Matthias Watzka, Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle. Antioxidants & Redox Signaling. ,vol. 8, pp. 347- 353 ,(2006) , 10.1089/ARS.2006.8.347